Dr Jonathan Slotkin Appointed to Peer Well Board of Directors

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

Dr Jonathan Slotkin was appointed as an independent board director.

A Harvard-trained neurosurgeon, Dr. Slotkin is currently Vice Chair of Neurosurgery at Geisinger as well as Chief Medical Officer of Contigo Health, a Premier Inc. company. Dr. Slotkin has been a long-time leader in the move towards multi-specialty musculoskeletal treatment and in offering accessible, digital health services to reshape healthcare delivery.

“As a physician, I’ve seen a lot of digital healthcare solutions, but the balance of tech and touch is always off. Touch—really taking care of patients—has been missing in the musculoskeletal space to date. We can’t successfully help patients with lasting improvement, and getting back to the activities they love, without the multi-disciplinary approach that PeerWell has embraced,” shares Dr. Slotkin.

Alongside the appointment, PeerWell is launching its new clinical practice, PeerWell Health. Three years in the making, PeerWell Health is a full-stack health care provider that offers access to live multi-specialty clinicians, including Physical and Occupational Therapists, Nutritionists, Mental Health Specialists, and Nurses—all guided by an assigned Care Coordinator. Patients with musculoskeletal issues, like back pain or hip and knee osteoarthritis, receive care from PeerWell’s licensed providers while also engaging with whole person, daily digital programs.

With 4 out of 10 adults in the U.S avoiding or delaying medical care due to concerns around COVID, there has been massive deterioration in the physical and mental health of those dealing with musculoskeletal issues. The launch of PeerWell Health was fast-tracked to treat the myriad of factors contributing to musculoskeletal conditions and to address multiple patient comorbidities.

Manish Shah, CEO of PeerWell, explains, “Treating one aspect of musculoskeletal health, like with physical therapy, is not enough. Truly helping patients struggling with pain and immobility means treating the interconnected factors that contribute to their condition. This is what drove us to build a multi-specialty network that can address the underlying issues stopping someone from achieving a full recovery, free of pain.”

PeerWell Health patients receive virtual care from PeerWell’s licensed providers while also engaging with content that reflects PeerWell’s holistic Five Pillars of Health and leverages its proprietary, SMART Motion™ technology. This comprehensive, multi-disciplinary approach, supported by a patient’s individual Care Coordinator, reduces the fragmentation of care, lowers healthcare delivery costs, and improves patient recovery times.

PeerWell Health services are already reimbursed by several major insurance plans today.

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles

Join our list

Subscribe to our mailing list and receive an end-of-week recap news and updates delivered right to your email inbox.